InvestorsHub Logo
Followers 58
Posts 10083
Boards Moderated 1
Alias Born 09/21/2016

Re: jimmy667 post# 111653

Tuesday, 07/18/2017 6:35:44 PM

Tuesday, July 18, 2017 6:35:44 PM

Post# of 459703
Jimmy, some day soon the trial practices of the last 40+ years will be used as examples of how far they have come and never again. Just like we judge those who <100 years ago thought that washing their hands prior to surgery was a waste of time or did not understand how/when to use antibiotics/sterilization/decontamination. Sad in a way but it is how we have learned till now.

The practice of running 100's of AD pts through trials where the side effects drove many to just give up and which at best only delayed eventual passing is being phased out, ASAP. Yet there are some who contrast and compare a new system to something that really never worked as not good enough, it just became the legacy practice...and must be right. This is the same gene pool who would now second guess A2-73 and not enough trial hours, pts, results when no molecule has EVER done what A2-73 has done. Get over it, you are toast.

Perhaps the most important fact is that there are no contradictions to Dr. M.'s thesis on Homeostasis in CNS diseases, yet there are numerous contradictions to the whole AD plaque thesis, it cannot be validated. IMO we are looking at smaller, faster trials which produce results based on precise science. That is code for you can be certain it will work before you start, just do the proper trial and it will work.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News